Bradshaw Start free trial

Crosstalk Therapeutics Ltd

Active

Data to 4 Nov 2026, 01:06

Company number
13162770
Sector
Not in a live sector
SIC group
Life sciences and health
Region
South East (Sandwich)
Incorporated
27 Jan 2021
SIC code
72110
Trading name
Not found
Website
Not found

Crosstalk Therapeutics Ltd has 1 priced round on record from share allotment filings at Companies House. The latest was allotted on 20 Jun 2024, raised £3.00m, and was filed on 16 Jul 2024. Data to 3 Nov 2026.

1

Priced rounds

Allotted Jun 2024

£3.00m

Cash raised in those rounds

Sum of sterling cash raised in each round, as filed

20 Jun 2024

Latest round allotted

Filed 16 Jul 2024

Jump to

Funding rounds

Priced equity rounds read from share allotment filings at Companies House, newest first.

Edit columns
Funding rounds for Crosstalk Therapeutics Ltd
Allotted First filed Cash raised Filing
20 Jun 2024Latest 16 Jul 2024 £3.00m Open filing
Price per share, post-money and step-ups for this round are in the full company page.

Companies with significant control

Companies with significant control over Crosstalk Therapeutics Ltd, from the register of people with significant control. A company can have control without holding shares. Individuals are not shown on public pages.

Edit columns
Companies with significant control
Holder Notified Ceased Shares held
Medicxi III LP 27 Jan 2021 20 Jun 2024 75 to 100%

From the PSC register.

Filings

The latest 1 capital filing other than share allotments (SH01), which are listed under Funding rounds. 2 share filings (SH01) have been read for this company.

Edit columns
Latest capital filings
Date Filing Document
23 Feb 2023 Resolution Open at Companies House

Documents open at Companies House. Bradshaw does not store or re-host them.

About this page

This page shows public register data for Crosstalk Therapeutics Ltd. Figures come from filings at Companies House; Bradshaw links to each filing and does not host copies. To correct or object to data about you, use the data request form.

Last updated 3 Nov 2026